{"id":5689,"date":"2026-08-03T07:29:25","date_gmt":"2026-08-03T07:29:25","guid":{"rendered":"https:\/\/echeloncreativemedia.com\/marketvows\/2026\/08\/03\/pharma-titans-eye-400-billion-megamerger-astrazeneca-and-bristol-myers-squibb-in-advanced-talks\/"},"modified":"2026-08-03T07:29:25","modified_gmt":"2026-08-03T07:29:25","slug":"pharma-titans-eye-400-billion-megamerger-astrazeneca-and-bristol-myers-squibb-in-advanced-talks","status":"publish","type":"post","link":"https:\/\/echeloncreativemedia.com\/marketvows\/2026\/08\/03\/pharma-titans-eye-400-billion-megamerger-astrazeneca-and-bristol-myers-squibb-in-advanced-talks\/","title":{"rendered":"Pharma Titans Eye $400 Billion Megamerger: AstraZeneca and Bristol Myers Squibb in Advanced Talks"},"content":{"rendered":"

Pharmaceutical giants AstraZeneca and Bristol Myers Squibb are reportedly in advanced discussions for a potential $400 billion megamerger, according to the Financial Times. If realized, this deal would be one of the largest in corporate history, creating a combined entity with significant market power, particularly in cancer and rare disease treatments, and reshaping the global pharmaceutical landscape.<\/p>\n

<\/p>\n

READ MORE FROM CNBC<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Pharmaceutical giants AstraZeneca and Bristol Myers Squibb are reportedly in advanced discussions for a potential $400 billion megamerger, according to the Financial Times. If realized, this deal would be one of the largest in corporate history, creating a combined entity with significant market power, particularly in cancer and rare disease treatments, and reshaping the global […]<\/p>\n","protected":false},"author":1,"featured_media":5690,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/image.cnbcfm.com\/api\/v1\/image\/108340298-17851337761785133772-47411763109-1080pnbcnews.jpg?v=1785133775&w=750&h=422&vtcrop=y","fifu_image_alt":"","footnotes":""},"categories":[28,29,33],"tags":[],"class_list":["post-5689","post","type-post","status-publish","format-standard","has-post-thumbnail","category-economy","category-global-affairs","category-world","rifnote_country-china","rifnote_country-u-s","rifnote_country-uk","rifnote_executive-pascal-soriot"],"fifu_image_url":"https:\/\/image.cnbcfm.com\/api\/v1\/image\/108340298-17851337761785133772-47411763109-1080pnbcnews.jpg?v=1785133775&w=750&h=422&vtcrop=y","_links":{"self":[{"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/posts\/5689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/comments?post=5689"}],"version-history":[{"count":0,"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/posts\/5689\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/media\/5690"}],"wp:attachment":[{"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/media?parent=5689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/categories?post=5689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/tags?post=5689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}